Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program, the dALi System, for Pediatric Type 1 Diabetes (T1D) Subjects

NCT05793645 is registered in ClinicalTrials.gov with Air Liquide Santé International as lead sponsor.

NCT NCT05793645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05793645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program, the dALi System, for Pediatric Type 1 Diabetes (T1D) Subjects
Lead sponsor
Air Liquide Santé International
Phase
Not applicable
Overall status
Unknown status
Start date
May 15, 2023
Completion date
March 30, 2024
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes